Bone marrow transplantation using unrelated and family related donors: The impact of HLA-C disparity

Bone Marrow Transplantation

Volumn 18, Issue 5, 1996, Pages 891-897

  Nagler, A ^a   Brautbar, C ^a   Slavin, S ^a   Bishara, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Graft rejection; Graft versus host disease; HLA disparity; Molecular HLA C typing; Transplant related mortality

Indexed keywords

HLA C ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DONOR; FAMILY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL TIME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HISTOCOMPATIBILITY TESTING; HLA-C ANTIGENS; HUMANS; MALE; TISSUE DONORS;

EID: 0029960675     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Westoff CF. Fertility in the United States. Science 1986; 234: 554-559.
2. Beatty PG, Dahlberg S, Mickelson EM et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988; 45: 714-718.
3. Vowels MR, Lam Po Tang R, Mameghan H et al. Bone marrow transplantation in children using closely matched related and unrelated donors. Bone Marrow Transplant 1991; 8: 87-92.
4. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
5. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
6. Anasetti C, Etzioni R, Petersdorf EW et al. Unrelated and HLA partially matched related donor transplants. Advances and controversies in bone marrow transplantation. Keystone Symposium on bone marrow transplantation. J Cell Biochem 1994; (Suppl. 18b): 49.
7. Slavin S, Nagler A. New developments in bone marrow transplantation. Curr Opin Oncol 1991; 3: 254-271.
8. Gale RP, Bortin MM, Van Bekkum DW et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397-406.
9. Ferrara JL, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
10. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med 1989; 320: 197-204.
11. Anasetti C, Beatty PG, Storb R et al. Effect of HLA incompatibility on graft-versus-host disease, relapse and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79-91.
12. Bozdech MJ, Sondel PM, Trigg ME et al. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. Exp Hematol 1985; 13: 1201-1210.
13. Van Bekkum DW. The double barrier in bone marrow transplantation. Semin Hematol 1974; 11: 325-340.
14. Uharek L, Gassmann W, Glass B et al. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 1992; 79: 1612-1621.
15. Hansen JA, Mickelson EM, Choo SY et al. Clinical bone marrow transplantation: donor selection and recipient monitoring. In: Rose NR, DeMacaric EC, Fahey JL (eds). Manual of Clinical Laboratory Immunology, 4th ed. American Society for Microbiology: Washington, DC, 1992, pp 850-866.
16. Petersdorf EW, Smith AG, Haase AM et al. Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing. Tissue Antigens 1991; 38: 169-177.
17. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993; 81: 1923-1932.
18. Santamaria P, Reinsmoen NL, Lindstrom AL et al. Frequent HLA class-I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 1994; 83: 280-287.
19. Snary B, Barnstable CJ, Bodmer WF, Crumpton MJ. Molecular structure of human histocompatibility antigens: the HLA-C series. Eur J Immunol 1977; 7: 580-585.
20. Baan CC, Vaessen LM, ten Kate F et al. Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 split. Transplantation 1993; 55: 438-439.
21. Dill O, Kievits F, Koch S et al. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc Natl Acad Sci USA 1988; 85: 5664-5668.
22. Colonna M, Spies T, Strominger JL et al. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci USA 1992; 89: 7983-7985.
23. Terasaki PI, Bernoco D, Park MS et al. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol 1978; 69: 103-120.
24. Browning MJ, Krausa P, Rowan A et al. Tissue Typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 1993; 90: 2842-2845.
25. Mickelson E, Smith A, McKinney S et al. A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucle-otide probes to PCR-amplified DNA. Tissue Antigens 1993; 41: 86-93.
26. Devender PD, Yunis I, Yunis EJ. Cellular typing: mixed lymphocyte response and cell-mediated lympholysis. In: Rose NR, Friedman H, Fahey JL (eds). Manual of Clinical Laboratory Immunology. American Society for Microbiology: Washington, 1992, pp 847-858.
27. Naparstek E, Hardan Y, Ben-Shahar M et al. Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant Interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 1992; 80: 1673-1678.
28. Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
29. Nagler A, Or R, Nisman B et al. Elevated inflammatory cytokine levels in bone marrow graft rejection. Transplantation 1995; 60: 1-3.
30. van Leeuwen JE, van Tol MJ, Bodzing BG et al. Detection of mixed chimaerism in flow-sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation. Br J Haematol 1991; 79: 218-225.
31. Barnard GA, Significance tests for 2×2 tables. Biometrika 1947; 34: 123-138.
32. Fisher RA. Statistical Methods for Research Workers, 5th edn. Oliver & Boyd: Edinburgh.
33. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Ass 1958; 53: 457-481.
34. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
35. Cox DR. Regression models and life-tables. J Royal Stat Soc, Ser B 1972; 34: 187-202.
36. Moretta A, Vitale M, Bottino C et al. P58 molecules as putative receptors for major histocompatibilily complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 atibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993; 178: 597-604.
37. Ciccone E, Pende D, Viale O et al. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992; 176: 963-971.
38. Lanier LL, Gumfperz JE, Parham P et al. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 1995; 154: 3320-3327.
39. Littaua RA, Oldstone MBA, Takeda A et al. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol 1991; 65: 4051-4056.
40. Imanishi T, Akaza T, Kimura A et al. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford University Press: Oxford, 1992, p 1065.
41. Bishara A, Amar A, Brautbar C et al. The putative role of HLA-C recognition in graft-versus-host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp Hematol 1995; 23: 1667-1675.
42. Scott I, Bunce M, Brookes P et al. The role of cellular and molecular class I HLA typing in selection of unrelated bone marrow donors. Exp Hematol 1995; 23: 744.
43. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
44. Beatty PG, Anasetti C, Hansen JA et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
45. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. Ann Intern Med 1993; 119: 207-214.
46. Powles RL, Morgenstern GR, Kay HE et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukemia. Lancet 1983; 1: 612-615.
47. Martinetti M, Locatelli F, Pizzochero C et al. Bone marrow transplantation in children using 'HLA-partially-matched' family donors. Bone Marrow Transplant 1993: 11 (Suppl. 1): 93-94.
48. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-550.